MARKET

TIL

TIL

Instil Bio, Inc.
NASDAQ
10.92
-0.48
-4.17%
After Hours: 11.34 +0.42 +3.85% 19:47 12/05 EST
OPEN
11.34
PREV CLOSE
11.40
HIGH
11.44
LOW
10.76
VOLUME
50.58K
TURNOVER
--
52 WEEK HIGH
42.79
52 WEEK LOW
10.70
MARKET CAP
74.06M
P/E (TTM)
-0.9585
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TIL last week (1124-1128)?
Weekly Report · 6d ago
Weekly Report: what happened at TIL last week (1117-1121)?
Weekly Report · 11/24 10:08
Weekly Report: what happened at TIL last week (1110-1114)?
Weekly Report · 11/17 10:08
Instil Bio Non-GAAP EPS of -$1.75 beats by $1.29
Seeking Alpha · 11/13 17:21
Instil Bio Q3 Adj. EPS $(1.75) Beats $(2.35) Estimate
Benzinga · 11/13 12:11
Instil Bio Q3 net loss per share narrows
Reuters · 11/13 12:09
*Instil Bio: Runway To Fund Operating Plan Beyond 2026 >TIL
Dow Jones · 11/13 12:09
*Instil Bio 3Q Loss/Shr $2.01 >TIL
Dow Jones · 11/13 12:07
More
About TIL
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. The Company’s subsidiary, Axion Bio, Inc., in-licensed certain bispecific antibodies, including AXN-2510/IMM2510 and AXN-27M/IMM27M, a monoclonal antibody targeting cytotoxic T-lymphocyte associated antigen 4, or CTLA-4. AXN-2510/IMM2510, the lead in-licensed product candidate, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumor cancers. AXN-27M/IMM27M is an antibody-dependent cellular cytotoxicity-enhanced monoclonal antibody targeting CTLA-4, which has been designed to promote intratumoral regulatory T cell depletion to enhance the efficacy and reduce the toxicity associated with first-generation anti-CTLA-4 antibodies.

Webull offers Instil Bio Inc stock information, including NASDAQ: TIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TIL stock methods without spending real money on the virtual paper trading platform.